Cargando…
Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes
The pathological hallmark of myelodysplastic syndromes (MDS) is marrow dysplasia, which represents the basis of the WHO classification of these disorders. This classification provides clinicians with a useful tool for defining the different subtypes of MDS and individual prognosis. The WHO proposal...
Autores principales: | Della Porta, Matteo G., Picone, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333741/ https://www.ncbi.nlm.nih.gov/pubmed/28293405 http://dx.doi.org/10.4084/MJHID.2017.017 |
Ejemplares similares
-
Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes
por: Aanei, Carmen Mariana, et al.
Publicado: (2016) -
Flow Cytometry in the Diagnosis of Myelodysplastic Syndromes
por: Kárai, Bettina, et al.
Publicado: (2013) -
Computational flow cytometry as a diagnostic tool in suspected‐myelodysplastic syndromes
por: Duetz, Carolien, et al.
Publicado: (2021) -
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group
por: Porwit, Anna, et al.
Publicado: (2022) -
The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review
por: Bento, Laiz Cameirão, et al.
Publicado: (2017)